Ten Strategies of Interferon Evasion by Viruses

Cell Host and Microbe

Volumn 22, Issue 2, 2017, Pages 176-184

  García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; ANTIVIRUS AGENT; VIRAL PROTEIN;

HUMAN; IMMUNE EVASION; INTERFERON INDUCTION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; RNA PROCESSING; UBIQUITINATION; VIRUS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS INTERFERENCE; VIRUS REPLICATION; VIRUS SURVIVAL; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY;

ANIMALS; ANTIVIRAL AGENTS; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERONS; PHOSPHORYLATION; VIRAL PROTEINS; VIRUS REPLICATION; VIRUSES;

EID: 85030718279     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.07.012     Document Type: Review

References (69)

1. Aguirre, S., Maestre, A.M., Pagni, S., Patel, J.R., Savage, T., Gutman, D., Maringer, K., Bernal-Rubio, D., Shabman, R.S., Simon, V., et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog., 8, 2012, e1002934.
2. Andrejeva, J., Childs, K.S., Young, D.F., Carlos, T.S., Stock, N., Goodbourn, S., Randall, R.E., The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 101 (2004), 17264–17269.
3. Ashour, J., Morrison, J., Laurent-Rolle, M., Belicha-Villanueva, A., Plumlee, C.R., Bernal-Rubio, D., Williams, K.L., Harris, E., Fernandez-Sesma, A., Schindler, C., García-Sastre, A., Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe 8 (2010), 410–421.
4. Beattie, E., Tartaglia, J., Paoletti, E., Vaccinia virus-encoded eIF-2 α homolog abrogates the antiviral effect of interferon. Virology 183 (1991), 419–422.
5. Bhattacharyya, S., Zagórska, A., Lew, E.D., Shrestha, B., Rothlin, C.V., Naughton, J., Diamond, M.S., Lemke, G., Young, J.A., Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe 14 (2013), 136–147.
6. Chatel-Chaix, L., Cortese, M., Romero-Brey, I., Bender, S., Neufeldt, C.J., Fischl, W., Scaturro, P., Schieber, N., Schwab, Y., Fischer, B., et al. Dengue Virus Perturbs Mitochondrial Morphodynamics to Dampen Innate Immune Responses. Cell Host Microbe 20 (2016), 342–356.
7. Chen, Q., Sun, L., Chen, Z.J., Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat. Immunol. 17 (2016), 1142–1149.
8. Daffis, S., Szretter, K.J., Schriewer, J., Li, J., Youn, S., Errett, J., Lin, T.Y., Schneller, S., Zust, R., Dong, H., et al. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468 (2010), 452–456.
9. Dalrymple, N.A., Cimica, V., Mackow, E.R., Dengue virus NS proteins inhibit RIG-I/MAVS signaling by blocking TBK1/IRF3 phosphorylation: Dengue virus serotype 1 NS4A is a unique interferon-regulating virulence determinant. MBio, 6, 2015 e00553–e15.
10. Davis, M.E., Wang, M.K., Rennick, L.J., Full, F., Gableske, S., Mesman, A.W., Gringhuis, S.I., Geijtenbeek, T.B., Duprex, W.P., Gack, M.U., Antagonism of the phosphatase PP1 by the measles virus V protein is required for innate immune escape of MDA5. Cell Host Microbe 16 (2014), 19–30.
11. Ding, B., Zhang, L., Li, Z., Zhong, Y., Tang, Q., Qin, Y., Chen, M., The matrix protein of human parainfluenza virus type 3 induces mitophagy that suppresses interferon responses. Cell Host Microbe 21 (2017), 538–547.e4.
12. Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I.Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33 (2003), 388–391.
13. Durbin, J.E., Hackenmiller, R., Simon, M.C., Levy, D.E., Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84 (1996), 443–450.
14. Etchison, D., Milburn, S.C., Edery, I., Sonenberg, N., Hershey, J.W., Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 257 (1982), 14806–14810.
15. Fan, L., Briese, T., Lipkin, W.I., Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J. Virol. 84 (2010), 1785–1791.
16. Ferrari, R., Gou, D., Jawdekar, G., Johnson, S.A., Nava, M., Su, T., Yousef, A.F., Zemke, N.R., Pellegrini, M., Kurdistani, S.K., Berk, A.J., Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection. Cell Host Microbe 16 (2014), 663–676.
17. Fonseca, G.J., Thillainadesan, G., Yousef, A.F., Ablack, J.N., Mossman, K.L., Torchia, J., Mymryk, J.S., Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe 11 (2012), 597–606.
18. Frias-Staheli, N., Giannakopoulos, N.V., Kikkert, M., Taylor, S.L., Bridgen, A., Paragas, J., Richt, J.A., Rowland, R.R., Schmaljohn, C.S., Lenschow, D.J., et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2 (2007), 404–416.
19. Fu, Y.Z., Su, S., Gao, Y.Q., Wang, P.P., Huang, Z.F., Hu, M.M., Luo, W.W., Li, S., Luo, M.H., Wang, Y.Y., Shu, H.B., Human Cytomegalovirus Tegument Protein UL82 Inhibits STING-Mediated Signaling to Evade Antiviral Immunity. Cell Host Microbe 21 (2017), 231–243.
20. Gack, M.U., Shin, Y.C., Joo, C.H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., Jung, J.U., TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446 (2007), 916–920.
21. Gack, M.U., Albrecht, R.A., Urano, T., Inn, K.S., Huang, I.C., Carnero, E., Farzan, M., Inoue, S., Jung, J.U., García-Sastre, A., Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5 (2009), 439–449.
22. Garaigorta, U., Chisari, F.V., Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 6 (2009), 513–522.
23. Geiger, T.R., Martin, J.M., The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells. J. Virol. 80 (2006), 11638–11650.
24. Gong, D., Kim, Y.H., Xiao, Y., Du, Y., Xie, Y., Lee, K.K., Feng, J., Farhat, N., Zhao, D., Shu, S., et al. A Herpesvirus Protein Selectively Inhibits Cellular mRNA Nuclear Export. Cell Host Microbe 20 (2016), 642–653.
25. Goodfellow, I., The genome-linked protein VPg of vertebrate viruses - a multifaceted protein. Curr. Opin. Virol. 1 (2011), 355–362.
26. Grant, A., Ponia, S.S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., Schwarz, M.C., Sánchez-Seco, M.P., Evans, M.J., Best, S.M., García-Sastre, A., Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host Microbe 19 (2016), 882–890.
27. Habjan, M., Andersson, I., Klingström, J., Schümann, M., Martin, A., Zimmermann, P., Wagner, V., Pichlmair, A., Schneider, U., Mühlberger, E., et al. Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE, 3, 2008, e2032.
28. Ho, B.C., Yu, S.L., Chen, J.J., Chang, S.Y., Yan, B.S., Hong, Q.S., Singh, S., Kao, C.L., Chen, H.Y., Su, K.Y., et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 9 (2011), 58–69.
29. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., Taniguchi, T., IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005), 772–777.
30. Hwang, S., Kim, K.S., Flano, E., Wu, T.T., Tong, L.M., Park, A.N., Song, M.J., Sanchez, D.J., O'Connell, R.M., Cheng, G., Sun, R., Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe 5 (2009), 166–178.
31. Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006), 101–105.
32. Kawai, T., Akira, S., TLR signaling. Cell Death Differ. 13 (2006), 816–825.
33. Kirchhoff, F., Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8 (2010), 55–67.
34. Kumar, K.G., Krolewski, J.J., Fuchs, S.Y., Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J. Biol. Chem. 279 (2004), 46614–46620.
35. Langland, J.O., Cameron, J.M., Heck, M.C., Jancovich, J.K., Jacobs, B.L., Inhibition of PKR by RNA and DNA viruses. Virus Res. 119 (2006), 100–110.
36. Laurent-Rolle, M., Morrison, J., Rajsbaum, R., Macleod, J.M.L., Pisanelli, G., Pham, A., Ayllon, J., Miorin, L., Martinez, C., tenOever, B.R., García-Sastre, A., The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. Cell Host Microbe 16 (2014), 314–327.
37. Li, X.D., Sun, L., Seth, R.B., Pineda, G., Chen, Z.J., Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102 (2005), 17717–17722.
38. Li, T., Chen, J., Cristea, I.M., Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe 14 (2013), 591–599.
39. Li, X.D., Wu, J., Gao, D., Wang, H., Sun, L., Chen, Z.J., Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341 (2013), 1390–1394.
40. Liu, J., HuangFu, W.C., Kumar, K.G., Qian, J., Casey, J.P., Hamanaka, R.B., Grigoriadou, C., Aldabe, R., Diehl, J.A., Fuchs, S.Y., Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 5 (2009), 72–83.
41. Liu, S.W., Katsafanas, G.C., Liu, R., Wyatt, L.S., Moss, B., Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses. Cell Host Microbe 17 (2015), 320–331.
42. Lubick, K.J., Robertson, S.J., McNally, K.L., Freedman, B.A., Rasmussen, A.L., Taylor, R.T., Walts, A.D., Tsuruda, S., Sakai, M., Ishizuka, M., et al. Flavivirus antagonism of type I interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression. Cell Host Microbe 18 (2015), 61–74.
43. Luthra, P., Ramanan, P., Mire, C.E., Weisend, C., Tsuda, Y., Yen, B., Liu, G., Leung, D.W., Geisbert, T.W., Ebihara, H., et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14 (2013), 74–84.
44. Mackenzie, J.M., Khromykh, A.A., Parton, R.G., Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2 (2007), 229–239.
45. Marazzi, I., Ho, J.S., Kim, J., Manicassamy, B., Dewell, S., Albrecht, R.A., Seibert, C.W., Schaefer, U., Jeffrey, K.L., Prinjha, R.K., et al. Suppression of the antiviral response by an influenza histone mimic. Nature 483 (2012), 428–433.
46. Mesman, A.W., Zijlstra-Willems, E.M., Kaptein, T.M., de Swart, R.L., Davis, M.E., Ludlow, M., Duprex, W.P., Gack, M.U., Gringhuis, S.I., Geijtenbeek, T.B., Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases. Cell Host Microbe 16 (2014), 31–42.
47. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., Tschopp, J., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005), 1167–1172.
48. Miller, S., Krijnse-Locker, J., Modification of intracellular membrane structures for virus replication. Nat. Rev. Microbiol. 6 (2008), 363–374.
49. Nemeroff, M.E., Barabino, S.M., Li, Y., Keller, W., Krug, R.M., Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3’end formation of cellular pre-mRNAs. Mol. Cell 1 (1998), 991–1000.
50. Pichlmair, A., Schulz, O., Tan, C.P., Näslund, T.I., Liljeström, P., Weber, F., Reis e Sousa, C., RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 (2006), 997–1001.
51. Pythoud, C., Rodrigo, W.W., Pasqual, G., Rothenberger, S., Martínez-Sobrido, L., de la Torre, J.C., Kunz, S., Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε. J. Virol. 86 (2012), 7728–7738.
52. Rodriguez, J.J., Parisien, J.P., Horvath, C.M., Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76 (2002), 11476–11483.
53. Sato, M., Tanaka, N., Hata, N., Oda, E., Taniguchi, T., Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-β gene. FEBS Lett. 425 (1998), 112–116.
54. Shaw, M.L., García-Sastre, A., Palese, P., Basler, C.F., Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J. Virol. 78 (2004), 5633–5641.
55. Stuart, J.H., Sumner, R.P., Lu, Y., Snowden, J.S., Smith, G.L., Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2. PLoS Pathog., 12, 2016, e1005955.
56. Symons, J.A., Alcamí A., Smith, G.L., Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81 (1995), 551–560.
57. Valmas, C., Grosch, M.N., Schümann, M., Olejnik, J., Martinez, O., Best, S.M., Krähling, V., Basler, C.F., Mühlberger, E., Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog., 6, 2010, e1000721.
58. Varga, Z.T., Grant, A., Manicassamy, B., Palese, P., Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J. Virol. 86 (2012), 8359–8366.
59. Venkataraman, T., Valdes, M., Elsby, R., Kakuta, S., Caceres, G., Saijo, S., Iwakura, Y., Barber, G.N., Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178 (2007), 6444–6455.
60. Versteeg, G.A., García-Sastre, A., Viral tricks to grid-lock the type I interferon system. Curr. Opin. Microbiol. 13 (2010), 508–516.
61. Vidy, A., Chelbi-Alix, M., Blondel, D., Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 79 (2005), 14411–14420.
62. von Kobbe, C., van Deursen, J.M., Rodrigues, J.P., Sitterlin, D., Bachi, A., Wu, X., Wilm, M., Carmo-Fonseca, M., Izaurralde, E., Carmo-Fonseca, M., Izaurralde, E., Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol. Cell 6 (2000), 1243–1252.
63. Weber, M., Sediri, H., Felgenhauer, U., Binzen, I., Bänfer, S., Jacob, R., Brunotte, L., García-Sastre, A., Schmid-Burgk, J.L., Schmidt, T., et al. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe 17 (2015), 309–319.
64. Wu, J.J., Li, W., Shao, Y., Avey, D., Fu, B., Gillen, J., Hand, T., Ma, S., Liu, X., Miley, W., et al. Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein. Cell Host Microbe 18 (2015), 333–344.
65. Xu, W., Edwards, M.R., Borek, D.M., Feagins, A.R., Mittal, A., Alinger, J.B., Berry, K.N., Yen, B., Hamilton, J., Brett, T.J., et al. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe 16 (2014), 187–200.
66. Yu, C.Y., Chang, T.H., Liang, J.J., Chiang, R.L., Lee, Y.L., Liao, C.L., Lin, Y.L., Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog., 8, 2012, e1002780.
67. Zhao, L., Jha, B.K., Wu, A., Elliott, R., Ziebuhr, J., Gorbalenya, A.E., Silverman, R.H., Weiss, S.R., Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 11 (2012), 607–616.
68. Zhao, J., Zeng, Y., Xu, S., Chen, J., Shen, G., Yu, C., Knipe, D., Yuan, W., Peng, J., Xu, W., et al. A Viral Deamidase Targets the Helicase Domain of RIG-I to Block RNA-Induced Activation. Cell Host Microbe 20 (2016), 770–784.
69. Zuniga, E.I., Liou, L.Y., Mack, L., Mendoza, M., Oldstone, M.B., Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. Cell Host Microbe 4 (2008), 374–386.